Safety and efficacy of insulin analog Novomix30 in Iranian patients with type 2 diabetes: results of the A1chieve study
Author(s):
Abstract:
Objective
The aim of this study was to assess the safety and efficacy of treatment with insulin analog Novomix30 in Iranian patients with type 2 diabetes using the results of the A1chieve study. Methods
The A1chieve study was a 24 week، open-label، multicenter، observational study of people with type 2 diabetes. The study was conducted in 28 countries across four continents on 66،726 people with type 2 diabetes، both insulin users and non-insulin users، to assess the safety and efficacy of Novomix30. This article reports the results of 919 Iranian patients with type 2 diabetes treated with insulin Novomix30. Results
After 24 weeks treatment with Novomix30، HbA1c reduced significantly (P<0. 001). Despite a significant reduction in fasting blood sugar and postprandial sugars، the incidence of severe and nocturnal hypoglycemia was significantly decreased in prior insulin users. The mean arterial blood pressure decreased significantly and the quality of life improved in all patients. Conclusion
Insulin Novomix30 was well tolerated despite good glycemic control and the incidence of hypoglycemia was not increased in Iranian patients with type 2 diabetes.Keywords:
Language:
Persian
Published:
Payesh, Volume:13 Issue: 6, 2014
Page:
705
magiran.com/p1334373
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!